Laigo Bio Secures €11.5Million Seed to Advance Suretac Therapies
Financing co-led by Kurma Partners and Curie Capital, includes strong line-up of European investors Laigo Bio, a company pioneering novel and highly differentiated therapies using its proprietary SureTAC precision...